BFI Infinity Ltd. Buys $3.06 Million Stake in McKesson Corporation

The investment firm added over 3,700 shares of the healthcare distribution giant to its portfolio.

Mar. 29, 2026 at 8:03am

Got story updates? Submit your updates here. ›

BFI Infinity Ltd. disclosed in a recent SEC filing that it purchased a new position in McKesson Corporation (NYSE: MCK) during the fourth quarter. The firm bought 3,725 shares of the company's stock, valued at approximately $3,056,000. McKesson now makes up 1.9% of BFI Infinity Ltd.'s investment portfolio, making it the 12th largest holding.

Why it matters

This investment highlights the continued institutional interest in McKesson, one of the largest healthcare services and distribution companies in the world. As a major player in pharmaceutical wholesale, logistics, and medical supply distribution, McKesson's performance is seen as a bellwether for the broader healthcare industry.

The details

According to the filing, BFI Infinity Ltd. added the McKesson shares to its portfolio during the fourth quarter of the year. The firm now holds 3,725 shares of the company's stock, valued at around $3.06 million. This represents 1.9% of BFI Infinity Ltd.'s total investments.

  • BFI Infinity Ltd. disclosed the new McKesson position in a Q4 2025 SEC filing.

The players

BFI Infinity Ltd.

An investment firm that manages a diversified portfolio of stocks, bonds, and other assets.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products, and healthcare technology solutions.

Got photos? Submit your photos here. ›

The takeaway

This investment by BFI Infinity Ltd. underscores the continued appeal of McKesson as a stable, well-performing healthcare distribution company. As the industry navigates evolving supply chains and regulatory changes, McKesson's size, scale, and diversified business model make it an attractive long-term holding for institutional investors.